Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2022-11-24 Regulatory Filings
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, in connection with declaration of unaudited standalone and consolidated ....
Regulatory Filings Classification · 95% confidence The document is a disclosure of Related Party Transactions for the half year ended 30th September 2022, submitted to stock exchanges as per SEBI regulations. It contains detailed financial data on transactions between the company and related parties, including amounts, nature of transactions, and approvals by the Audit Committee. The document is 8658 characters long, which is substantial and contains actual financial data rather than just an announcement or certification. The content aligns with regulatory requirements for disclosure of related party transactions, which is typically part of regulatory filings but not a full financial report like an Annual or Interim Report. Given the detailed nature and regulatory context, this fits best under Regulatory Filings (RNS), as it is a compliance disclosure document rather than a full financial report or management discussion.
2022-11-24 English
Newspaper Advertisements
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the publication of unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2022. It mentions that the financial results were approved on 10th November 2022 and published in newspapers on 11th November 2022. The document includes newspaper advertisements of these financial results and states that these are also available on the company's website. The document itself does not contain the full financial statements or detailed financial analysis but is an announcement of the publication of the financial results. Therefore, it is not the actual Interim/Quarterly Report (IR) but rather a Report Publication Announcement (RPA). The document length (13,038 characters) is relatively short and consistent with an announcement rather than a full report. Hence, the correct classification is RPA with high confidence.
2022-11-11 English
Newspaper Advertisements - Unaudited standalone and consolidated financial results of the company for the quarter and half year ended 30th September 2022, approved on 10th November 2022
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the publication of unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2022. It mentions that the financial results were approved on 10th November 2022 and published in newspapers on 11th November 2022. The document includes newspaper advertisements of these financial results and is signed by the company secretary. The content is an announcement about the publication of financial results, not the financial results report itself. The document length is about 13,000 characters, but the content is primarily a notification of publication rather than the full financial report or detailed financial data. Therefore, according to the "Menu vs Meal" rule, this is a Report Publication Announcement (RPA) rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2022-11-11 English
Loss of share certificate
Regulatory Filings
2022-11-11 English
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find attached herewith ....
Regulatory Filings
2022-11-11 English
General updates
Regulatory Filings
2022-11-10 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.